Press Releases | Recent Articles

February 1, 2021

Tetsuya Kawagishi appointed as President and CEO of Canon Medical Systems Europe

Zoetermeer, The Netherlands, 1 February 2021 – Canon Medical has today announced the appointment of Tetsuya Kawagishi as President and CEO of Canon Medical Systems Europe. The move, which comes at a critical time for healthcare providers around the world, reflects the business’s unwavering commitment to partnership, innovation, and effective communication as key drivers for success.

October 23, 2020

CANON MEDICAL PROVIDES THE LATEST CAPABILITIES IN CT SIMULATION FOR RADIATION ONCOLOGY WITH NEW AQUILION EXCEED LB

Giving clinicians the opportunity to see more during radiation therapy planning, Canon Medical Systems is introducing the Aquilion Exceed LB CT scanner (pending 510(k) clearance) during this year’s virtual American Society for Radiation Oncology (ASTRO) Annual Meeting.

July 27, 2020

Canon Medical and FC Barcelona renew five-season partnership deal

Canon Medical and FC Barcelona have today announced a renewal of their partnership deal, which will see the medical device company supplying the club with leading-edge diagnostic imaging systems for a further five seasons.

July 27, 2020

Canon Medical to partner with Real Madrid until 2025

Canon Medical and Real Madrid have today announced that the Japanese medical device company will remain the club’s official diagnostic imaging partner for a further five seasons.

June 22, 2020

CANON MEDICAL PARTNERS WITH LEADING RUSSIAN HEALTHCARE PROVIDER R-PHARM

Canon Medical Systems Corporation (Headquarters: Otawara, Tochigi Prefecture, Japan; President and CEO: Toshio Takiguchi, herein after Canon Medical) has agreed on establishing a joint venture with leading Russian healthcare provider, R-Pharm Holding, LLC (Headquarters: Moscow, Russia; Chairman: Alexey Repik, herein after R-Pharm), for sales and maintenance of diagnostic imaging equipment manufactured by Canon Medical in nine CIS member states, including Russia, and will consummate the joint venture when all the necessary regulatory approvals are obtained.

Contact Us